For an analysis of the potential cases dealing solely with the drug DES see Comment, DES and a Proposed Theory of Enterprise Liability, Fordham Law Review 46(5):963 (April 1978).
2.
Texas recently became the 49th state to adopt such legislation.
3.
Sindell v. Abbott Laboratories, 607 P.2d 924 (Cal. 1980), cert. denied, 449 U.S. 912(1980).
4.
Id. at 937.
5.
Summers v. Tice, 199 P.2d 1 (Cal. 1948); The Restatement (Second) of Torts §443B has approved the rule of this case.
6.
Summers, supra note 5, at 3, quoting Oliver v. Miles, 110 So. 666, 668. (Miss. 1927).
7.
Sindell, supra note 3, at 930.
8.
Id. at 937.
9.
Id.
10.
Ybarra v. Spangard, 154 P.2d 687 (Cal. 1944).
11.
Id. at 691.
12.
Ybarra v. Spangard, 208 P.2d 445 (Cal. App. 1949). (In the original Ybarra v. Spangard, supra note 11, the court remanded the case to allow the defendants an opportunity to overcome the inference of negligence. They were unable to do so; judgment was entered for the plaintiff and affirmed on appeal).
13.
Frost v. Des Moines Still College of Osteopathy, and Surgery, 79 N.W.2d 306 (Iowa 1956); Beaudom v. Watertown Memorial Hospital, 145 N.W.2d 166 (Wisc. 1966); Kitto v. Gilbert, 570 P.2d 544 (Colo. App. 1977).
14.
Rhodes v. DeHaan, 337 P.2d 1043 (Kan. 1959); Talbot v. Dr. W. H. Groves' Latter-Day Saints Hospital, Inc., 440 P.2d 872 (Utah 1968).
